Archive for November, 2008

Research Done With Levitra And The Eyes

Sunday, November 23rd, 2008

New research done with the erectile dysfunction medication Levitra shows that men who use it do not experience a negative impact on their orbital hemodynamics and the IOP in their eyes. The research that was done in Turkey by Doctor Taner and his team at the school of medicine based in the University of Kirikkale looked specifically at how Levitra affected the eyes. They looked at IOP, systemic blood pressure and orbital hemodynamics paying particular attention to the peak systolic velocity, the end-diastolic velocity and the resistive index scores of the ophthalmic, posterior ciliary and central retina arteries.
I am sure that you are all thinking what the hell are we talking about? Yes, we admit it at Ukmedix News we didn’t have a clue either! However we can tell you this…. erectile dysfunction medications Viagra, Cialis and Levitra have in extremely rare cases been linked to a condition called NAION and we are not going to confuse you more by explaining what it stands for. However this eye condition can induce temporary and in very very rare cases permanent blindness in men.

The study done with the Levitra medication was obviously done to test how the blood flow to the eyes is affected by the use of a PDE-5 inhibitor like Levitra and the researchers could not report any clinically significant changes in the systolic blood pressure however they did register that there was a significant lowering in the diastolic blood pressure after the use of the Levitra.  The researchers also said that they had noted a clinically significant rise in the end-diastolic velocity of the central retinal artery however this was not the same for the orbital blood flow speed in the ophthalmic artery as well as for the posterior ciliary artery.

The study was done on 21 men who suffered from erectile dysfunction and the results were published in the clinical publication called the Journal of Ocular Pharmacology and Therapeutics.

All we can say at this point at Ukmedix News is that if there really was any serious or dangerous changes in blood pressure in the areas around the eyes with the use of the erectile dysfunction medication Levitra these researchers would have found it. Also the three erectile dysfunction medications which have been used by millions and millions of men all around the world have never been proven to have caused 1 single case of NAION.

Levitra Hard Sell

Tuesday, November 18th, 2008

Bayer the makers of the erectile dysfunction medication Levitra are determined to win market share from their big rivals Viagra and Cialis and in a new marketing campaign they are promising to give cost of the drug back to any men who use the Levitra and fail to have a satisfactory erection as a result. Some medical professionals however feel that Bayer have overstepped the mark for the ethical marketing of prescription drugs and that the money back guarantee gives men very high and possibly misleading expectations about erectile dysfunction drugs.

In Australia where the manoy back guarantee is being conducted Bayer HealthCare is encouraging doctors to give out a ‘Levitra guarantee’ with the prescription for Levitra, saying that Bayer will refund the 70 Australian dollars for the 4 pack if the drug doesn’t work. The guarantee makes it clear that the word of the patient will be enough for them to get their money back and they won’t need to provide proof! It is unlikely that men will apply for their money back as they will have to go through the humiliating experience of admitting impotence for only a 70 Australian dollar refund. In Scandanavia Bayer ran a similar guarantee and around 2% of men applied for a refund. However independent tests show that about 80% of men who use Levitra get good results with the drug.

The intensive marketing campaign is being promoted in the press and the adverts (which very clearly don’t break the rules on the adverts for prescription drugs by mentioning the word Levitra) simply encourages men with erectile dysfunction problems to men to go to a web site where they can get a performance pack that will be sent to their doctor who in turn will issue a prescription.

Bayer HealthCare are treading very carefully these days after they were fined 100,000 Australian dollars in 2005 for overstepping the rules on the promotion of prescription medicines, however this new campaign has so far not attracted the attention of the medical authorities and is primarily an ED awareness campaign and is designed to break down the barrier between patients and doctor with regard to erectile dysfunction.

This marketing deal is running all through summer until September is probably the best attempt yet from Bayer to increase its market share and really get an edge on Viagra and Cialis.

Levitra Testing Shows Good Results For Men With Dyslipidemia

Friday, November 7th, 2008

Some good news for the manufacturers of the erectile dysfunction medication Levitra is that a clinical trial that looked at the drug saw that it could be extremely effective in helping men who suffer from the impotence condition due to high cholesterol levels.
High cholesterol is one of the major causes of bad erectile function and can lead to the condition known as dyslipidemia. This in turn can aggravate arteriosclerosis which is the condition that causes hardening of the arteries. Since good blood flow is essential for good erectile function men suffering from arterial problems will almost certainly have impaired sexual function.

Levitra like its rival drugs Viagra and Cialis is a PDE 5 inhibitor which means that it will help to open up the penile artery and facilitate healthy blood flow to the penis. This study evaluated the effect of the Levitra drug on men with high cholesterol and was done using a placebo controlled and double blind methodology. This study is the first one to evaluate the effectiveness and safety of the Levitra drug specifically in men suffering from dyslipidemia and erectile dysfunction.

It is estimated that around three quarters of men who suffer from erectile dysfunction also suffer from either hypertension, dyslipidemia, high cholesterol or diabetes. Levitra has the lowest sales figures out of the three erectile dysfunction drugs on the market today however this does not mean that it is less effective than the other two. In independent testing it has been shown to be just as effective as Viagra and Cialis and some men prefer it and say it works better for them than the other two.

Levitra is manufactured in Europe by the German drug company Bayer Pharmaceuticals and its active ingredient is called vardenafil.